The National Agency for Pharmaceutical Materials granted an additional three-month deadline for pharmaceutical institutions to complete the appointment of pharmacovigilance officials, in a step aimed at strengthening the monitoring of the safety of medicines after their marketing. The decision came in response to the requests of those dealing in the sector, while emphasizing the necessity of appointing qualified people to monitor and report side effects of medicines, within the framework of tightening control over drug security and protecting […] The post: 90 days for drug producers and importers to adhere to these conditions! appeared first on Al-Shorouk Online.